Effet de l’alimentation maternelle sur le gain de poids au cours de la grossesse

ObjectivesTo assess maternal intakes of energy and nutrients in each trimester of pregnancy and their effect on gestational weight gain.Materials and methodsA prospective and longitudinal study of a cohort of 300 women was carried out during the entire period of pregnancy at antenatal consultation and monitoring centers in Constantine (Algeria) from December 2013 to July 2016. The estimation of energy and nutrient intakes was made by a three-day dietary record and repeated each trimester of pregnancy. Height and starting weight and weight at the end of pregnancy were measured. Statistics were performed using StatviewTM and SPSS software.ResultsThe majority of women (75.0%) had inadequate weight gain in late pregnancy. Intakes of energy, vitamines and minerals of women with low weight gain were lower than that of women with normal and excessive gain in the three trimesters of pregnancy (P < 0.0001). For all weight categories, average energy and nutrient intakes were lower in the first trimester then increase in the second trimester and stabilized in the third trimester. Between the first and third trimesters, 86 to 100% of women had vitamin and mineral intakes that were significantly lower than recommended dietary allowance.ConclusionOur study demonstrated the impact of maternal nutrition on gestational weight gain in relation to energy intake and specific nutrients, but the role of macronutrients was inconsistent. Pregnancy should be used as a ‘window of opportunity’ for changes in diet.     

Antibacterial and anticandidal screening of Tunisian Citrullus colocynthis Schrad. from Medenine

Ethnopharmacological relevance

Resistance to current antibacterial drugs and the rise of opportunistic fungal infections are growing global concerns. Traditional medicine is a potential source of new antibacterials and antifungals. Citrullus colocynthis Schrad. (Cucurbitaceae) endemic in Southern Tunisia, is used in folk medicine against dermatological, gynaecological and pulmonary infections.

Aim of study

To assess in vitro antibacterial and anticandidal activity of aqueous and diluted acetone extracts of Citrullus colocynthis Schrad. MIC and MBC/MFC were determined for plant organs at different maturation stages.

Materials and methods

Citrullus colocynthis Schrad. was harvested and its identification was verified. Aqueous and diluted acetone extracts (from the plant's roots, stems, leaves and three maturation stages of its fruit and seeds) were screened for activity against Gram-negative and Gram-positive bacteria (Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Enterococcus faecalis)—and various Candida spp. (Candida glabrata, Candida albicans, Candida parapsilosis and Candida kreusei).

Results

All extracts showed activity against all strains. The highest MICs and MBCs/MFCs were obtained from the fruit aqueous extracts (MIC 0.10 mg/ml against Candida albicans and Candida glabrata, 0.20 mg/ml against Escherichia coli and Pseudomonas aeruginosa), lowest activity from the root extracts.

Conclusions

Citrullus colocynthis Schrad. shows antibacterial and anticandidal properties. The folk medicinal use as a broad-spectrum antimicrobial agent is validated.     

Lichen amyloidosis successfully treated with fractional ablative laser CO2: A new alternative therapeutic

Lichen amyloidosis is a primary localized cutaneous amyloidosis. Different types of treatment have been used without complete resolution. Herein, we report a case of patient suffering from lichen amyloidosis successfully treated with fractional ablative laser CO₂. He was a 59-year-old man diagnosed lichen amyloidosis localized on the legs 10 years ago. He was treated with topical corticosteroids without any improvement. Then, we started treating the affected area with CO₂ laser (limmer*) at a setting of 5–8 J/cm² and 8 mm laser spot size. A considerable improvement was noticed after the first session. A total healing was reported after four sessions. To the best of our knowledge, only 11 reported cases of lichen amyloidosis have been successfully treated with laser CO₂. However, our clinical finding seems to be one of the best reported results.     

Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: effect of probiotics and prebiotics

Inflammatory bowel disease (IBD) consists mainly of Ulcerative colitis (UC) and Crohn disease (CD). Although its aetiology is still not clearly established, it is thought to be due to overly aggressive immune response to enteric bacteria in genetically predisposed individuals. Manipulating the microbiota using probiotics or prebiotics is considered as a promising field of new therapeutic strategies used to attenuate immune disorders observed during IBD. The production of nitric oxide (NO) seems to be implicated in IBD pathogenesis. In our study, an acute UC was induced in Swiss mice using 3% Dextran Sulfate Sodium (DSS). The preventive effects of "Ultrabiotique?" (a probiotic) and inulin (a prebiotic) on the colitis were investigated. The production of NO was evaluated in the supernatants of peritoneal macrophages (pMφ) cultures. Colonic mucosa histology was subsequently examined. Results showed severe acute UC after administration of DSS. High levels of NO in pMφ cultures were also observed compared to control samples. These findings correlated with a significant destruction of the colonic mucosa. Oral administration of Ultrabiotique? or inulin decreased the severity of DSS-induced colitis. These treatments lead to a decrease in NO levels in pMφ cultures. A considerable reduction of colonic lesions was also noticed. Our findings suggest the involvement of NO in experimental UC pathogenesis. Pre- and pro-biotics, as discussed herein, seem to have an anti-inflammatory effect.     

Ecthyma Gangrenosum Caused by Escherichia coli in a Previously Healthy Girl

Ecthyma gangrenosum is a characteristic lesion of Pseudomonas aeruginosa sepsis in immunocompromised patients. Only eight cases of ecthyma gangrenosum caused by Escherichia coli have been reported. We report a case of ecthyma gangrenosum due to E. coli without bacteremia in a previously healthy girl.     

Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session

PURPOSE

A magnetic resonance imaging-ultrasonography (MRI-US) fusion-guided prostate biopsy increases detection rates compared to an extended sextant biopsy. The imaging characteristics and pathology outcomes of subsequent biopsies in patients with initially negative MRI-US fusion biopsies are described in this study.

MATERIALS AND METHODS

We reviewed 855 biopsy sessions of 751 patients (June 2007 to March 2013). The fusion biopsy consisted of two cores per lesion identified on multiparametric MRI (mpMRI) and a 12-core extended sextant transrectal US (TRUS) biopsy. Inclusion criteria were at least two fusion biopsy sessions, with a negative first biopsy and mpMRI before each.

RESULTS

The detection rate on the initial fusion biopsy was 55.3%; 336 patients had negative findings. Forty-one patients had follow-up fusion biopsies, but only 34 of these were preceded by a repeat mpMRI. The median interval between biopsies was 15 months. Fourteen patients (41%) were positive for cancer on the repeat MRI-US fusion biopsy. Age, prostate-specific antigen (PSA), prostate volume, PSA density, digital rectal exam findings, lesion diameter, and changes on imaging were comparable between patients with negative and positive rebiopsies. Of the patients with positive rebiopsies, 79% had a positive TRUS biopsy before referral (P = 0.004). Ten patients had Gleason 3+3 disease, three had 3+4 disease, and one had 4+4 disease.

CONCLUSION

In patients with a negative MRI-US fusion prostate biopsy and indications for repeat biopsy, the detection rate of the follow-up sessions was lower than the initial detection rate. Of the prostate cancers subsequently found, 93% were low grade (≤3+4). In this low risk group of patients, increasing the follow-up time interval should be considered in the appropriate clinical setting.Prostate cancer is the most common cancer in males, with an estimated 238 590 new diagnoses annually in the USA, and it is the second leading cause of cancer-related mortality in males (1). One in six males will develop prostate cancer in his lifetime (1). The current standard of care for diagnosing and grading prostate cancer is a 12-core extended sextant biopsy obtained with transrectal ultrasonography (TRUS) guidance (2, 3). As magnetic resonance imaging (MRI) has superior contrast resolution than ultrasonography (US), it is possible for multiparametric MRI (mpMRI) to detect prostate cancer with high reliability (4). Since clinically insignificant cancer is often invisible to magnetic resonance (MR), prostate MRI preferentially detects more aggressive cancers (5–9). MRI can be used to guide the prostate biopsy, either using a direct “in-gantry” approach or by using MRI-US fusion, which was developed as an office-based alternative (10). MRI-US targeted biopsies have about twice the per-core detection rate of sextant biopsies (11), and have been shown to be particularly useful for prostates measuring greater than 40 mL, which typically have lower rates of cancer detection than smaller prostate glands (12).Since TRUS-guided biopsies have a relatively low sensitivity, many patients with a rising prostate-specific antigen (PSA), but an initial negative biopsy, undergo additional biopsies with progressively lower yields. In a study of sequential systematic biopsies in 1051 males, the detection rate of successive biopsies was 22%, 10%, 5%, and 4%, respectively (13). The third and fourth TRUS-guided biopsy sessions detected lower grade cancers and were found to have higher morbidity than the first two biopsies. Recently, MRI-US fusion biopsy has been reported to increase cancer detection rates in the setting of a prior negative TRUS biopsy (14, 15).While MRI-US fusion biopsy is promising in the setting of previous negative random sampling, the response to a negative MRI-US fusion biopsy is less clear. Since a MRI-US fusion biopsy increases prostate cancer detection, this population should have a lower disease burden than patients with an initial negative TRUS-guided biopsy alone. Now that MRI-US fusion biopsies have been available for several years, such data are beginning to accumulate. Here, we investigate the detection rates of subsequent biopsies in patients with an initial negative MRI-US fusion prostate biopsy.     

Alimentation, activité physique et surpoids chez des enfants de l’est Algérien

The prevalence of overweight and obesity were measured in a sample of 251 children aged 8 to 12 year in an urban area of the Eastern part of Algeria. IOTF references are used in order to define overweight and obesity.The overall prevalence of overweight and obesity is 21.5 %. 15.9 %. Overweight alone is found in 15.9% and obesity in 5,6 % of the children. Obese children consume less often a breakfast and less milk than that normal weight children and eat more often high fat, high carbohydrates foods. Mean caloric intakes are similar. Meals and snacking take often place while watching television. Energy percent derived from proteins but not their absolute amount and fat intakes are higher in overweight children. Most of the overweight children (78 %) do not practice any sport activity. Fat intake adjusted on energy intake is positively correlated with sport duration.This preliminary study suggest that childhood obesity is now a public health threat in Algeria.